סקוקינומאב (Hebrew Wikipedia)

Analysis of information sources in references of the Wikipedia article "סקוקינומאב" in Hebrew language version.

refsWebsite

Global rank Hebrew rank

6doi.org

2^nd place

10^th place

3nih.gov

4^th place

18^th place

2hcplive.com

low place

1medicines.org.uk

3,823^rd place

3,380^th place

1europa.eu

68^th place

170^th place

1nature.com

234^th place

92^nd place

1science.org

1,160^th place

787^th place

1genengnews.com

low place

1patents.google.com

1,182^nd place

1,541^st place

1fda.gov

447^th place

285^th place

1web.archive.org

1^st place

6^th place

1novartis.com

low place

4,670^th place

doi.org

dx.doi.org

Aaron L. Nelson, Eugen Dhimolea, Janice M. Reichert, Development trends for human monoclonal antibody therapeutics, Nature Reviews Drug Discovery 9, 2010-10, עמ' 767–774 doi: 10.1038/nrd3229
Wolfgang Hueber, Dhavalkumar D. Patel, Thaddeus Dryja, Andrew M. Wright, Irina Koroleva, Gerard Bruin, Christian Antoni, Zoe Draelos, Michael H. Gold, the Psoriasis Study Group, Patrick Durez, Paul P. Tak, Juan J. Gomez-Reino, the Rheumatoid Arthritis Study Group, C. Stephen Foster, Rosa Y. Kim, C. Michael Samson, Naomi S. Falk, David S. Chu, David Callanan, Quan Dong Nguyen, the Uveitis Study Group, Kristine Rose, Asifa Haider, Franco Di Padova, Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis, Science Translational Medicine 2, 2010-10-06 doi: 10.1126/scitranslmed.3001107
Matt Shirley, Lesley J. Scott, Secukinumab: A Review in Psoriatic Arthritis, Drugs 76, 2016-07-01, עמ' 1135–1145 doi: 10.1007/s40265-016-0602-3
Nupur U. Patel, Nora C. Vera, Emily Rose Shealy, Margaret Wetzel, Steven R. Feldman, A Review of the Use of Secukinumab for Psoriatic Arthritis, Rheumatology and Therapy 4, 2017-08-28, עמ' 233–246 doi: 10.1007/s40744-017-0076-0
Ennio Lubrano, Fabio Massimo Perrotta, Secukinumab for ankylosing spondylitis and psoriatic arthritis, Therapeutics and Clinical Risk Management 12, 2016-10-21, עמ' 1587–1592 doi: 10.2147/TCRM.S100091

doi.org

Matt Shirley, Lesley J. Scott, Secukinumab: A Review in Psoriatic Arthritis, Drugs 76, 2016-07-01, עמ' 1135–1145 doi: 10.1007/s40265-016-0602-3

europa.eu

ema.europa.eu

Cosentyx | European Medicines Agency, www.ema.europa.eu

fda.gov

accessdata.fda.gov

Drug Approval Package: Brand Name (Generic Name) NDA #, www.accessdata.fda.gov

genengnews.com

GEN Staff Writer, Novartis Snags Remaining 23% Stake in Alcon with $12.9B Cash and Share Deal, GEN - Genetic Engineering and Biotechnology News, ‏2010-12-15 (באנגלית אמריקאית)

hcplive.com

Healthcare, Medical News & Expert Insight | HCPLive, HCP Live (באנגלית)
FDA Approves Intravenous Variant of Secukinumab for Psoriatic Arthritis, Other Arthritis Types, HCP Live, ‏2023-10-06 (באנגלית)

medicines.org.uk

Cosentyx 150mg and 300mg solution for injection in pre-filled syringe and pre-filled pen - Summary of Product Characteristics (SmPC) - (emc), www.medicines.org.uk

nature.com

Aaron L. Nelson, Eugen Dhimolea, Janice M. Reichert, Development trends for human monoclonal antibody therapeutics, Nature Reviews Drug Discovery 9, 2010-10, עמ' 767–774 doi: 10.1038/nrd3229

nih.gov

ncbi.nlm.nih.gov

Nupur U. Patel, Nora C. Vera, Emily Rose Shealy, Margaret Wetzel, Steven R. Feldman, A Review of the Use of Secukinumab for Psoriatic Arthritis, Rheumatology and Therapy 4, 2017-08-28, עמ' 233–246 doi: 10.1007/s40744-017-0076-0
Ennio Lubrano, Fabio Massimo Perrotta, Secukinumab for ankylosing spondylitis and psoriatic arthritis, Therapeutics and Clinical Risk Management 12, 2016-10-21, עמ' 1587–1592 doi: 10.2147/TCRM.S100091

dailymed.nlm.nih.gov

DailyMed - COSENTYX- secukinumab injection COSENTYX- secukinumab injection, solution, concentrate, dailymed.nlm.nih.gov

novartis.com

Novartis receives two new FDA approvals for Cosentyx to treat patients with ankylosing spondylitis and psoriatic arthritis in the US, Novartis (באנגלית)

patents.google.com

IL-17 antagonistic antibodies (באנגלית), נבדק ב-2024-03-03

science.org

Wolfgang Hueber, Dhavalkumar D. Patel, Thaddeus Dryja, Andrew M. Wright, Irina Koroleva, Gerard Bruin, Christian Antoni, Zoe Draelos, Michael H. Gold, the Psoriasis Study Group, Patrick Durez, Paul P. Tak, Juan J. Gomez-Reino, the Rheumatoid Arthritis Study Group, C. Stephen Foster, Rosa Y. Kim, C. Michael Samson, Naomi S. Falk, David S. Chu, David Callanan, Quan Dong Nguyen, the Uveitis Study Group, Kristine Rose, Asifa Haider, Franco Di Padova, Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis, Science Translational Medicine 2, 2010-10-06 doi: 10.1126/scitranslmed.3001107

web.archive.org

FDA approves new psoriasis drug Cosentyx, web.archive.org, ‏2015-01-22